Genentech, Inc.
| Article | Date | Source |
|---|
| FDA Notifies Genentech of Violations at Avastin Plant | -- | News - BioPharm |
| Pertuzumab to bolster Roche/Genentech's breast cancer franchise? | -- | Nature Biotechnology |
| Roche (RHHBY)'s Genentech (RHHBY)'s Drug Positive in Mid-Stage Skin Cancer Trial | -- | Pharmaceutical - Moreover |
| The Quality Product Steward Model: The Genentech Approach | -- | Outsourcing - BioPharm |
| Roche cuts Genentech jobs | -- | Nature Biotechnology |
| Symphogen Receives Milestone Payment from Genentech for Antibody... | -- | PRWeb - Biotechnology |
| Wassim Nashabeh of Genentech Joins the Editorial Advisory Board of BioPharm International | -- | Outsourcing - BioPharm |
| Genentech Highlights SACHEM's Displacers to Isolate and Scale-up... | -- | PRWeb - Biotechnology |
| Genentech Highlights SACHEM’s Displacers at AICHE 2009 | -- | PRWeb - Biotechnology |
| UCSF Enters Drug Discovery Agreement with Genentech | -- | PRWeb - Biotechnology |
| FDA commits to quick review of new Genentech breast cancer drug | February 07, 2012 | Health News - BizJournals.com |
| FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis | January 30, 2012 | Xconomy Life Sciences |
| Genentech skin cancer drug with deep Bay Area ties wins FDA approval | January 30, 2012 | Health News - BizJournals.com |
| FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis | January 30, 2012 | Xconomy Life Sciences |
| Roche Settles Claims Over Genentech's Raptiva Psoriasis Drug, Lawyer Says | January 24, 2012 | BioSpace - Breaking News |
| Genentech And Constellation Forge Epigenetics Agreement | January 23, 2012 | Biotechnology - Moreover |
| Genentech Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms | January 17, 2012 | BioSpace |
| Genentech Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Buys Option to Acquire | January 17, 2012 | BioSpace |
| Genentech Pours $95M Into Constellation’s Drug Platform | January 17, 2012 | Xconomy Life Sciences |
| Constellation, Genentech ink cancer partnership, including M&A terms | January 17, 2012 | Health News - BizJournals.com |
| Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration | January 17, 2012 | Pharma News - Business Wire |
| Genentech Pours $95M Into Constellation’s Epigenetic Drug Platform | January 17, 2012 | Xconomy Life Sciences |
| Genentech Partners with Xenon Pharmaceuticals in $646M Pain Pact | January 13, 2012 | Burrill Report |
| Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics | January 09, 2012 | Pharma News - PR Newswire |
| Vernalis PLC Signs Drug-Discovery Deal With Genentech | January 04, 2012 | BioSpace |
| Regeneron settles with Genentech over eye drug | January 03, 2012 | Health News - CNBC |
| Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection | January 03, 2012 | Biotech News - PR Newswire |
| Genentech: The Beginnings of Biotech | December 30, 2011 | Burrill Report |
| Pfizer elects former Genentech exec to board | December 13, 2011 | Health News - BizJournals.com |
| Genentech Initiates First-in-Human Study with NovImmune’s Anti-IL17 Antibody | December 13, 2011 | b3c newswire |
| Combo of Genentech's Herceptin, new drug delays spread of breast cancer — study | December 08, 2011 | Health News - BizJournals.com |
| Genentech's Two-Drug Strategy Raises the Bar in Breast Cancer, Positive Phase III Results Reported | December 08, 2011 | BioSpace |
| Genentech Announces Positive Results of Pivotal Phase III Study with pertuzumab in HER2-Positive Metastatic Breast Cancer | December 07, 2011 | Pharma News - Business Wire |
| Genentech to pay $20M in Rituxan whistleblower suit | December 05, 2011 | FiercePharma |
| Genentech settles whistleblower suit | December 02, 2011 | Health News - BizJournals.com |
| Genentech settles Rituxan whistleblower suit for $20M | December 02, 2011 | Health News - BizJournals.com |
| Genentech Looks to Turn the Page at Breast Cancer Confab | December 01, 2011 | Xconomy Life Sciences |
| Genentech Looks to Turn the Page, Impress with New Antibody at Upcoming Breast Cancer Confab | December 01, 2011 | Xconomy Life Sciences |
| Genentech Settles FCA Suit Over Cancer Drug For $20M | December 01, 2011 | Biotechnology - Moreover |
| Genentech to Present Important New Data for HER2-Positive Breast Cancer at | November 30, 2011 | BioSpace - Breaking News |
| Genentech to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium | November 30, 2011 | Pharma News - Business Wire |
| Genentech's Avastin Ousted by FDA for Breast Cancer, Sunshine Biopharma, Inc. Gears-Up for Clinicals | November 29, 2011 | BioSpace - Breaking News |
| Research and Markets: Partnering Agreements with Genentech - Provides the user with the tools to make successful contact with the right partners effectively | November 24, 2011 | Pharmaceutical - Moreover |
| Regulatory Roundup: FDA Holds Special Press Briefing Regarding Revocation of Genentech's Avastin | November 23, 2011 | Pharmaceutical - Moreover |
| FDA Rejects Genentech's Avastin for Breast Cancer | November 18, 2011 | BioSpace |
| FDA Rejects Genentech's Avastin for Breast Cancer? | November 18, 2011 | BioSpace |
| FDA Revokes Approval of Genentech's Avastin for Breast Cancer | November 18, 2011 | BioSpace |
| Genentech's early days offer lesson for today's biotechs | November 18, 2011 | Health News - BizJournals.com |
| Former Genentech CEO takes chairman's role at Apple | November 16, 2011 | FiercePharma |
| Apple Taps Former Genentech Chief as New Chairman | November 16, 2011 | BioSpace |
| Genentech's Levinson tapped as new Apple chairman | November 16, 2011 | FierceBiotech |
| Apple names Genentech chairman Arthur Levinson to head board, replacing Steve Jobs | November 16, 2011 | Biotechnology - Moreover |
| Apple names Genentech chairman Arthur Levinson to head board, replacing Steve Jobs. | November 15, 2011 | Biotechnology - Moreover |
| Genentech Skin Cancer Drug Gets FDA Priority Review | November 09, 2011 | BioSpace |
| Plant check reveals Genentech report flaw repeat | November 08, 2011 | FiercePharma Manufacturing |
| Genentech Release: Data Showed ACTEMRA Monotherapy Significantly Improved Signs and Symptoms of Rheumatoid Arthritis | November 07, 2011 | BioSpace - Breaking News |
| San Mateo County, Genentech in $26.5M tax deal | November 04, 2011 | Health News - BizJournals.com |
| Genentech Sues University of Pennsylvania Over Patent | October 28, 2011 | BioSpace |
| Birth of biotech: Revisiting Genentech's glory days | October 26, 2011 | Biotechnology - Moreover |
| Genentech's Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years | October 20, 2011 | BioSpace - Breaking News |
| Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends | October 20, 2011 | Biotech News - PR Newswire |
| 3,500 Patient Identities at Risk After Genentech Breach | October 14, 2011 | Biotechnology - Moreover |
| New label on Genentech's Avastin warns of infertility | October 04, 2011 | Health News - BizJournals.com |
| Genentech cancer drug performs well in trial | September 26, 2011 | Health News - BizJournals.com |
| Genentech antibody-chemo punch strong in breast cancer trial | September 26, 2011 | Health News - BizJournals.com |
| Roche, Genentech researchers avoid business talk | September 23, 2011 | Health News - CNBC |
| Genentech Says Prior Suit Bars HGS' Antitrust Claims | September 20, 2011 | Biotechnology - Moreover |
| J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs | September 15, 2011 | Xconomy Life Sciences |
| Genentech seeks FDA OK for skin cancer drug | September 12, 2011 | Health News - BizJournals.com |
| Curis, Inc. Partner Genentech Sends Cancer Drug to FDA | September 12, 2011 | BioSpace |
| Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer
| September 12, 2011 | BioSpace |
| Genentech Submits NDA for Skin Cancer Drug | September 12, 2011 | Contract Pharma |
| Genentech Seeks FDA Clearance for Next Skin Cancer Drug | September 12, 2011 | Xconomy Life Sciences |
| Curis partner Genentech sends cancer drug to FDA | September 12, 2011 | Health News - BizJournals.com |
| Curis Announces Submission of New Drug Application by Collaborator Genentech for Vismodegib in Advanced Basal Cell Carcinoma | September 12, 2011 | Pharma News - Business Wire |
| Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer | September 12, 2011 | FDA News - Business Wire |
| Biologics, Inc. Selected by Genentech as Strategic Partner for Launch of New Targeted Oral Oncology Therapy | September 07, 2011 | Pharma News - Business Wire |
| Galapagos NV and Genentech Extend Drug Discovery Collaboration for About $35 Million | August 18, 2011 | BioSpace - Breaking News |
| Galapagos, Genentech Extend Discovery Pact | August 18, 2011 | Contract Pharma |
| Galapagos gains third extension of Genentech deal in $35M pact | August 18, 2011 | FierceBiotech |
| Galapagos and Genentech extend drug discovery collaboration | August 18, 2011 | Marketwire - Pharma and Biotech |
| Genentech melanoma drug, companion diagnostic win FDA approval | August 17, 2011 | Health News - BizJournals.com |
| Gilead gains clinical supply ops in Genentech plant buy | August 09, 2011 | FiercePharma Manufacturing |
| Genentech unloads buildings to Gilead | August 09, 2011 | FiercePharma |
| Gilead buying Genentech manufacturing facility | August 09, 2011 | Health News - BizJournals.com |
| Genentech to pay $28M for cancer drug deal with Array | August 09, 2011 | Health News - BizJournals.com |
| Gilead Sciences, Inc. to Purchase Biologics Plant From Genentech | August 09, 2011 | BioSpace |
| Array BioPharma, Inc., Genentech Ink $713 Million Oncology Pact | August 09, 2011 | BioSpace |
| Gilead Buys Genentech Clinical Facility | August 09, 2011 | Contract Pharma |
| Array adds $713M cancer drug pact with Genentech to deal roster | August 09, 2011 | FierceBiotech |
| Genentech to sell clinical scale biologics plant to Gilead | August 09, 2011 | Pharmaceutical - Moreover |
| Genentech to pay $28M in cancer drug deal with Array | August 09, 2011 | Health News - BizJournals.com |
| Gilead Buys Genentech Biologics Plant | August 08, 2011 | Xconomy Life Sciences |
| Gilead to buy Genentech manufacturing facility | August 08, 2011 | Health News - BizJournals.com |
| Array BioPharma lands Genentech drug-development deal | August 08, 2011 | Health News - BizJournals.com |
| Gilead buying Genentech facility | August 08, 2011 | Health News - BizJournals.com |
| Genentech pitches Avastin compromise to FDA | August 08, 2011 | FiercePharma |
| Genentech Takes Another Shot at Convincing FDA to Keep Avastin Available for "Appropriate" Breast Cancer Patients | August 08, 2011 | BioSpace |
| Genentech: Keep Avastin available for 'appropriate' breast cancer patients | August 05, 2011 | Health News - BizJournals.com |
| Genentech Takes Another Shot at Convincing FDA to Maintain Avastin’s Metastatic Breast Cancer Approval | August 05, 2011 | Inside Industry - Gen |
| Genentech's New Drug Shows Promise in Fighting Breast Cancer | August 05, 2011 | BioSpace |
| Genentech drug looks promising in early breast-cancer trial | August 05, 2011 | FierceBiotech |
| Genentech: Breast cancer drug hits its mark | July 15, 2011 | Health News - BizJournals.com |
| Genentech Drug Impresses in Phase III Trial; to Seek Approval by Year End | July 15, 2011 | BioSpace - Breaking News |
| Nevada State Judge Denies Roche and Genentech's Motions to Dismiss PDL BioPharma's Complaint | July 11, 2011 | Biotech News - PR Newswire |
| Genentech patent may be key to cancer drug maker's IPO | July 09, 2011 | Health News - BizJournals.com |
| A Billion-Dollar "No" Vote for Genentech | June 30, 2011 | Burrill Report |
| Genentech finds companions on road to drug development | June 30, 2011 | Health News - BizJournals.com |
| FDA panel rejects Genentech's Avastin for breast cancer | June 29, 2011 | Health News - BizJournals.com |
| Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer | June 29, 2011 | Pharma News - Business Wire |
| Genentech Shot Down at FDA Hearing on Avastin for Breast Cancer | June 29, 2011 | Xconomy Life Sciences |
| Genentech Buys Rights to Forma Drug, Nimbus Gets $24M, Lilliputian Adds $11M, & More Boston-Area Deals News | June 29, 2011 | Xconomy Life Sciences |
| Genentech Options Forma’s Preclinical Cancer Program | June 28, 2011 | Burrill Report |
| Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer | June 28, 2011 | Xconomy Life Sciences |
| Genentech Announces Two Pivotal Phase III Lucentis Studies Showed Patients With Diabetic Macular Edema Experienced Significant Improvements in Vision and Fewer Developed More Advanced Retinopathy | June 28, 2011 | BioSpace |
| Genentech's Mipomersen Data Presented at | June 28, 2011 | BioSpace - Breaking News |
| Genentech warms biotechs and shareholders with deals | June 28, 2011 | Health News - BizJournals.com |
| Genentech Nabs Rights to a Forma Therapeutics Preclinical-Stage Anticancer Program | June 28, 2011 | Inside Industry - Gen |
| Genentech Nabs Rights to a Forma Therapeutics Preclinical-Stage Anticancer Program | June 28, 2011 | Inside Industry - Gen |
| Genentech warms biotechs, shareholders with deals | June 28, 2011 | Health News - BizJournals.com |
| Genentech Scoops Up Tumor-Starving Drug Program From FORMA Therapeutics In Rare Deal
| June 27, 2011 | BioSpace |
| Genentech leaves the numbers blank in Forma deal | June 27, 2011 | FierceBiotech |
| Genentech in FDA showdown over Avastin | June 27, 2011 | Health News - BizJournals.com |
| Genentech buys rights to Forma cancer drug program | June 27, 2011 | Health News - BizJournals.com |
| Genentech cancer deal kicks off BIO convention | June 27, 2011 | Health News - BizJournals.com |
| FORMA Therapeutics Grants Genentech Exclusive Rights to Acquire a Pre-clinical Cancer Program | June 27, 2011 | Pharma News - Business Wire |
| Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal | June 27, 2011 | Xconomy Life Sciences |
| Genentech to Appeal to F.D.A. for Breast Cancer Drug | June 26, 2011 | New York Times- Pharmaceuticals |
| Genentech's Investigational Skin Cancer Drug Found Effective In Mid-stage Study | June 20, 2011 | Pharmaceutical - Moreover |
| Roche's Genentech's Drug Positive in Mid-Stage Skin Cancer Trial | June 20, 2011 | BioSpace |
| Pivotal Study Results Lead Genentech to Project Vismodegib Filing in U.S. During 2011 | June 20, 2011 | Inside Industry - Gen |
| Genentech's Avastin slows ovarian cancer | June 06, 2011 | Health News - BizJournals.com |
| INSERTING and REPLACING Genentech Announces Vemurafenib Improved Survival in People With Metastatic Melanoma Who Have BRAF V600 Mutations | June 05, 2011 | Pharma News - Business Wire |
| Genentech Announces Vemurafenib Improved Survival in People With Metastatic Melanoma Who Have BRAF V600 Mutations | June 05, 2011 | Pharma News - Business Wire |
| Genentech Announces Data to Show Avastin-Based Regimen Halved the Risk of Disease Getting Worse in Women with Recurrent Ovarian Cancer | June 04, 2011 | Pharma News - Business Wire |
| Genentech and Novartis Remain Image Leaders in Oncology and Hematology | June 02, 2011 | Biotech News - PR Newswire |
| Marshall Edwards Adds Former Genentech Head of Medical Affairs Robert Mass as Chief Medical Officer | June 02, 2011 | Medical Pharma - PR Newswire |
| Genentech scientists blaze a trail into the brain for antibodies | May 26, 2011 | FierceBiotech |
| Roche/Genentech - The 12 greenest companies in biopharma | May 20, 2011 | FiercePharma Manufacturing |
| Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine | May 18, 2011 | Xconomy Life Sciences |
| Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO | May 18, 2011 | Pharma News - Business Wire |
| Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry | May 17, 2011 | Xconomy Life Sciences |
| Genentech veteran Stephen Juelsgaard named to stem cell agency board | May 16, 2011 | Health News - BizJournals.com |
| U of L doctor part of study showing benefits of less-expensive Genentech drug | May 06, 2011 | Health News - BizJournals.com |
| Genentech lobbies for Lucentis as eye study looms | April 28, 2011 | FiercePharma |
| Sanofi Free To Appeal Genentech Patent Ruling | April 21, 2011 | Pharmaceutical - Moreover |
| Roche’s Genentech sues Novartis unit claiming infringement | April 21, 2011 | Health News - BizJournals.com |
| FDA approves Genentech's Actemra against rare Still's disease in children | April 15, 2011 | Health News - BizJournals.com |
| Activist patients join Genentech's Avastin campaign | April 08, 2011 | FiercePharma |
| Early-stage Genentech cancer drug combo shows promise | April 04, 2011 | Health News - BizJournals.com |
| Genentech sees promise in combining experimental cancer drugs | April 04, 2011 | FierceBiotech |
| Gilead Antes Up for Cancer, Genentech Eye Drug Passes Big Trial, Bigger Isn’t Better, & More Bay Area Life Sciences News | April 01, 2011 | Xconomy Life Sciences |
| Pfizer, Genentech and APP initiate recalls | March 28, 2011 | FiercePharma |
| Genentech Eye Drug, Under Scrutiny, Passes Study in Diabetic Patients to Open Up New Market | March 25, 2011 | Xconomy Life Sciences |
| Genentech Release: Second Lucentis Phase III Study Meets Primary Endpoint for Improved Vision in Patients with Diabetic Macular Edema (DME) | March 25, 2011 | BioSpace - Breaking News |
| Achaogen hires Genentech veteran as chief medical officer | March 22, 2011 | Health News - BizJournals.com |
| Genentech skin cancer drug passes Phase II test | March 21, 2011 | Health News - BizJournals.com |
| Genentech aBCC Drug Meets Phase II Endpoint | March 21, 2011 | Contract Pharma |
| Genentech Gets Positive Result in Cancer Trial | March 21, 2011 | Xconomy Life Sciences |
| Genentech and Curis' Basal Cell Carcinoma Drug Meets Primary Endpoint in Pivotal Study | March 21, 2011 | Inside Industry - Gen |
| Curis, Genentech announce cancer drug study result | March 21, 2011 | Health News - CNBC |
| Curis, Inc. Announces Positive Results in Genentech Pivotal Phase II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma | March 21, 2011 | BioSpace |
| Curis Announces Positive Results in Genentech Pivotal Phase II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma | March 21, 2011 | Pharma News - Business Wire |
| Genentech Announces Positive Pivotal Phase II Results for Hedgehog Pathway Inhibitor in Advanced Basal Cell Carcinoma | March 21, 2011 | Pharma News - Business Wire |
| Genentech's Lucentis eye drug works well in trial - but all eyes are on NIH study | March 10, 2011 | Health News - BizJournals.com |
| Genentech Phase III Study of Lucentis Showed Rapid Vision Improvements Sustained for Two Years in Patients with Diabetic Macular Edema | March 10, 2011 | BioSpace |
| Genentech Gets US Hearing on Avastin, Breast Cancer | February 25, 2011 | BioSpace - Breaking News |
| Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News | February 25, 2011 | Xconomy Life Sciences |
| Genentech Gets FDA Hearing | February 24, 2011 | Xconomy Life Sciences |
| FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States | February 24, 2011 | Pharma News - Business Wire |
| Genentech's Lucentis does well in study of diabetic eye condition | February 11, 2011 | Health News - BizJournals.com |
| Genentech: Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME) | February 11, 2011 | BioSpace |
| Nebulizers: Research from Genentech Broadens Understanding of Nebulizers | February 03, 2011 | Pharmaceutical - Moreover |
| Study links Genentech's Avastin to deadly side effects | February 02, 2011 | Health News - BizJournals.com |
| FDA Approves Genentech's Rituxan for First-Line Maintenance Use in Follicular Lymphoma | January 31, 2011 | BioSpace |
| Pharmaceutical and Biomedical Analysis: Reports from Genentech Highlight Recent Research in Pharmaceutical and Biomedical Analysis | January 27, 2011 | Pharmaceutical - Moreover |
| Genentech Fires Back at FDA Over Avastin for Breast Cancer
| January 19, 2011 | BioSpace |
| Genentech cites chemo comparisons in Avastin appeal | January 19, 2011 | FiercePharma |
| Genentech Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer | January 19, 2011 | Pharma News - Business Wire |
| Pharmaceutical Sciences: Researchers from Genentech report on findings in pharmaceutical sciences | January 15, 2011 | Pharmaceutical - Moreover |
| Genentech Informs Customers of Important Information About Triad Group's Alcohol Prep Pads | January 14, 2011 | Pharma News - Business Wire |
| Spirogen signs agreement with Genentech for antibody drug conjugates | January 06, 2011 | Biotechnology - Moreover |
| Plexxikon Signs Agreement With Genentech to Co-Promote PLX4032 in the US | January 06, 2011 | Pharma News - Business Wire |
| Spirogen Ltd. Announces a Research Collaboration and License Agreement With Genentech for the Discovery and Development of Antibody Drug Conjugates | January 06, 2011 | Biotech News - PR Newswire |
| AMRI, Genentech enter licensing agreement | January 05, 2011 | Biotechnology - Moreover |
| Genentech Licenses AMRI Compounds | January 04, 2011 | Xconomy Life Sciences |
| AMRI, Genentech Enter Research Pact | January 04, 2011 | Contract Pharma |
| Genentech asks for Avastin hearing | December 27, 2010 | Health News - BizJournals.com |
| Pharmaceutical and Research: Research conducted at Genentech has provided new information about pharmaceutical and research | December 18, 2010 | Pharmaceutical - Moreover |
| Genentech Loses Avastin Battle, Fluidigm’s Second Chance at an IPO, Ion Torrent’s Debut, & More Bay Area Life Sciences News | December 17, 2010 | Xconomy Life Sciences |
| Adimab signs agreement with Genentech to identify human antibodies | December 16, 2010 | Biotechnology - Moreover |
| Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States | December 16, 2010 | Pharma News - Business Wire |
| Adimab inks deals with Lilly, Genentech and HGS | December 15, 2010 | FierceBiotech |
| Adimab, Inc. Announces New Discovery Programs with Eli Lilly and Company, Genentech and Human Genome Sciences, Inc. | December 15, 2010 | BioSpace |
| Adimab Announces New Discovery Programs with Eli Lilly, Genentech and Human Genome Sciences | December 15, 2010 | Biotech News - Business Wire |
| Roche's Genentech's Herceptin and Pertuzumab Plus Chemotherapy Significantly Helps Women With Newly Diagnosed, Early-Stage Breast Cancer in Phase II Study | December 10, 2010 | BioSpace |
| Genentech breathes new life into failed breast cancer drug | December 10, 2010 | FierceBiotech |
| Roche's Genentech's Herceptin and GlaxoSmithKline's Pertuzumab Plus Chemotherapy Significantly Helps Women With Newly Diagnosed, Early-Stage Breast Cancer in Phase II Study | December 10, 2010 | BioSpace |
| Genentech: positive results from cancer drug study | December 05, 2010 | Health News - CNBC |
| Immunoglobulins: Reports from Genentech add new data to research in immunoglobulins | December 05, 2010 | Biotechnology - Moreover |
| Growing Number of Health Plans Will Implement Additional Cost-Sharing Measures to Cover Orally-Administered Oncology Drugs Such as Novartis' Gleevec and Genentech's Tarceva | November 23, 2010 | Pharma News - PR Newswire |
| Genentech to cut up to 750 Bay Area jobs | November 18, 2010 | Pharmaceutical - Moreover |
| Pharmacokinetics: Reports from Genentech describe recent advances in pharmacokinetics | November 18, 2010 | Biotechnology - Moreover |
| Genentech spends $1.2 million lobbying in 3Q | November 17, 2010 | Biotechnology - Moreover |
| Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared | November 17, 2010 | Xconomy Life Sciences |
| Genentech (RHHBY)'s ECP-1 Bacterial Manufacturing Facility Named 2010 Facility of the Year Awards Overall Winner | November 09, 2010 | Pharmaceutical - Moreover |
| Genentech's ECP-1 Bacterial Manufacturing Facility Named 2010 Facility of the Year Awards Overall Winner | November 08, 2010 | Pharmaceutical - Moreover |
| Genentech Release: ACTEMRA Data Presented at American College of Rheumatology Annual Meeting on Rapid Response and Long-Term Efficacy in People with Rheumatoid Arthritis | November 08, 2010 | BioSpace - Breaking News |
| Pfizer, Genentech tout arthritis drug test data | November 08, 2010 | Health News - CNBC |
| Roche's Genentech and Plexxikon Inc.'s Melanoma Drug Shows Promise In Phase II Study | November 05, 2010 | BioSpace |
| Genentech Reports Promising Phase II Results with New Targeted Approach in Advanced Melanoma | November 04, 2010 | Pharma News - Business Wire |
| Genentech tries rebates to goose Lucentis use | November 04, 2010 | FiercePharma |
| Genentech Offers Secret Rebates to Promote Lucentis | November 03, 2010 | New York Times- Pharmaceuticals |
| Genentech promotes Teeter to VP of corporate relations | October 25, 2010 | Biotechnology - Moreover |
| Roche Holding AG (RHHBF.PK), Biogen Idec, Inc. (Massachusetts) (BIIB)'s Genentech (RHHBY) End Dispute Over Rituxan Follow-Ons | October 22, 2010 | Biotechnology - Moreover |
| Biogen Idec, Inc. (Massachusetts) (BIIB), Roche Holding AG (RHHBF.PK)'s Genentech (RHHBY) End Dispute Over Rituxan Follow-Ons | October 22, 2010 | Biotechnology - Moreover |
| Biogen Idec, Inc. (Massachusetts), Roche Holding AG's Genentech End Dispute Over Rituxan Follow-Ons | October 22, 2010 | BioSpace - Breaking News |
| BIG Pharma is out and about at this years AusBiotech as Roche and US subsidiary Genentech step up their partner search while Merck and Pfizer join them to explain to an audience what large pharmaceutical companies look for in a partnering deal. | October 22, 2010 | Pharmaceutical - Moreover |
| Biogen Idec and Genentech Tweak Anti-CD20 Alliance to Prevent Future Squabbles | October 22, 2010 | Inside Industry - Gen |
| Roche Holding AG, Biogen Idec, Inc. (Massachusetts)'s Genentech End Dispute Over Rituxan Follow-Ons | October 22, 2010 | BioSpace |
| Biogen, Genentech Restructure Antibody Pact | October 22, 2010 | Contract Pharma |
| Resumen: Biogen Idec y Genentech anuncian modificación en su acuerdo de colaboración de anticuerpos anti-CD20 | October 22, 2010 | Pharma News - Business Wire |
| Samenvatting: Biogen Idec en Genentech melden herstructurering anti-CD20 samenwerkingsovereenkomst | October 22, 2010 | Pharma News - Business Wire |
| Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News | October 22, 2010 | Xconomy Life Sciences |
| Biogen Idec et Genentech annoncent la restructuration de l’accord de collaboration existant sur l’anticorps anti-CD20 | October 22, 2010 | Pharma News - Business Wire |
| Biogen, Genentech amend deal on MS drug | October 21, 2010 | Health News - CNBC |
| Riassunto: Biogen Idec e Genentech annunciano la revisione dell'accordo di collaborazione anti CD20 | October 21, 2010 | Pharma News - Business Wire |
| Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement | October 21, 2010 | Pharma News - Business Wire |
| Biogen, Genentech Revamp Alliance | October 21, 2010 | Xconomy Life Sciences |
| Biogen, Genentech say MS drug met goal in study | October 15, 2010 | Health News - CNBC |
| Phase II Study with Genentech and Biogen Idec, Inc. (Massachusetts)'s Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients | October 15, 2010 | BioSpace |
| Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News | October 15, 2010 | Xconomy Life Sciences |
| Curis, Genentech Begin Phase II Skin Cancer Trial | October 11, 2010 | Contract Pharma |
| Genentech vet sets up deal-making shop | October 11, 2010 | FierceBiotech |
| Biotechnology: Studies from Genentech provide new data on biotechnology | October 07, 2010 | Biotechnology - Moreover |
| Biotechnology: New biotechnology research from Genentech described | September 24, 2010 | Biotechnology - Moreover |
| Biotechnology: New findings from Genentech in the area of biotechnology published | September 21, 2010 | Biotechnology - Moreover |
| Biotechnology: Investigators at Genentech publish new data on biotechnology | September 20, 2010 | Biotechnology - Moreover |
| Genentech Provides Update on Avastin for Advanced Breast Cancer | September 17, 2010 | Pharma News - Business Wire |
| Genentech exec leaving for Rockefeller U. | September 17, 2010 | Health News - BizJournals.com |
| Roche CEO: Genentech R&D will remain independent | September 15, 2010 | Health News - BizJournals.com |
| Genentech CEO Leaves Dendreon Corporation Board | September 15, 2010 | BioSpace |
| CEO: Roche, Genentech R&D won't merge | September 15, 2010 | FierceBiotech |
| Electrolytes: Data from Genentech advance knowledge in electrolytes | September 15, 2010 | Pharmaceutical - Moreover |
| Genentech CEO Leaves Dendreon Board | September 14, 2010 | Xconomy Life Sciences |
| Argenta expands collaboration with Genentech to include BioFocus | September 14, 2010 | Pharma News - PharmiWeb |
| Genentech breast cancer drug on trial | September 13, 2010 | Health News - BizJournals.com |
| Argenta Discovery Ltd. Expands Collaboration with Genentech to Include BioFocus DPI | September 10, 2010 | BioSpace - Breaking News |
| Argenta Adds BioFocus to Genentech Pact | September 10, 2010 | Contract Pharma |
| Top Genentech (RHHBY) Research Exec Departing For Rockefeller University | September 09, 2010 | Biotechnology - Moreover |
| Top Genentech Research Exec Departing For Rockefeller University | September 09, 2010 | BioSpace |
| Genentech R&D honcho heads to Rockefeller U. | September 09, 2010 | FierceBiotech |
| Genentech example raises flags for Genzyme | September 07, 2010 | Biotechnology - Moreover |
| ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA | August 27, 2010 | Xconomy Life Sciences |
| Review of Genentech cancer drug rejected | August 27, 2010 | Health News - BizJournals.com |
| Roche, Genentech hit with refuse-to-file letter | August 27, 2010 | FierceBiotech |
| Genentech Receives Refuse to File Letter from FDA for T-DM1 | August 27, 2010 | FDA News - Business Wire |
| Genentech Provides Update on FDA Application for T-DM1 | August 27, 2010 | Pharma News - Business Wire |
| Genentech spent $1.3 million lobbying in 2Q | August 19, 2010 | Biotechnology - Moreover |
| PDL BioPharma, Inc. Says Genentech Claims Drugs Don't Breach EU Patents; Stocks Fall 16.13% at 1:34PM EDT | August 13, 2010 | BioSpace |
| PDL BioPharma, Inc. Says Genentech Claims Drugs Don't Breach EU Patents; Stocks Fall 17.10% at 10:34AM EDT | August 13, 2010 | BioSpace - Breaking News |
| PDL BioPharma, Inc. Says Genentech Claims Drugs Don't Breach EU Patents | August 13, 2010 | BioSpace |
| Former Genentech executive named Inspire’s chief medical officer | August 13, 2010 | Health News - BizJournals.com |
| PDL BioPharma Receives Letter from Genentech Relating to European Patents | August 13, 2010 | Medical Pharma - PR Newswire |
| FDA Extends Use Of Genentech Transplant Drug Valcyte | August 11, 2010 | BioSpace - Breaking News |
| FDA extends use of Genentech transplant drug | August 10, 2010 | Health News - BizJournals.com |
| Genentech: More study needed on Curis drug | August 09, 2010 | Health News - BizJournals.com |
| Curis, Inc. Provides Update on Genentech's Phase II Clinical Trial of GDC-0449 in Advanced Ovarian Cancer Patients; Primary Analysis Warrant Additional Investigation, Stock Falls | August 09, 2010 | BioSpace |
| Curis shares sink as Genentech evaluates lead drug's fate | August 09, 2010 | FierceBiotech |
| Curis, Inc. Provides Update on Genentech's Phase II Clinical Trial of GDC-0449 in Advanced Ovarian Cancer Patients; Primary Analysis Warrant Additional Investigation | August 09, 2010 | BioSpace - Breaking News |
| Genentech Inks Antibody Deal, Cytokinetics Sticks With Science First, BioMarin Scraps Drug, & More Bay Area Life Sciences News | August 06, 2010 | Xconomy Life Sciences |
| Genentech pays $12M to expand Seattle Genetics pact | August 03, 2010 | Health News - BizJournals.com |
| Seattle Genetics, Genentech Expand Antibody Drug Pact | August 03, 2010 | Contract Pharma |
| Seattle Genetics, Inc. Gets $12 Mln From Genentech's Roche For Rights; Deal Potentially Worth $900 Million | August 03, 2010 | BioSpace |
| Seattle Genetics gets $12M in expanded Genentech deal | August 03, 2010 | Health News - BizJournals.com |
| Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies” | August 03, 2010 | Xconomy Life Sciences |
| IDBS Customers Pfizer and Genentech Deliver Keynotes at IQPC's ELN Conference | July 28, 2010 | Marketwire - Pharma and Biotech |
| NovImmune SA Eyes IPO After Licensing Deal With Roche's Genentech | July 27, 2010 | BioSpace |
| Genentech licenses antibody from Swiss company | July 26, 2010 | Health News - BizJournals.com |
| NovImmune SA Enters Exclusive Antibody Licensing Agreement with Genentech | July 26, 2010 | BioSpace - Breaking News |
| Datamonitor Report: Roche/Genentech's Avastin Faces Breast Cancer Setback But Will Likely Retain Leading Position In Oncology | July 23, 2010 | BioSpace |
| Tethys Pockets $33M, Achaogen’s Vision for Antibiotics, Genentech Strikes Out at FDA Panel, & More Bay Area Life Sciences News | July 23, 2010 | Xconomy Life Sciences |
| Roche credits Genentech acquisition for big profit rise | July 22, 2010 | Health News - BizJournals.com |
| Roche Profit Up on Genentech Synergies | July 22, 2010 | Pharmaceutical - Moreover |
| Genentech Provides Update From Avastin Genentech Advisory Committee Meeting | July 21, 2010 | BioSpace - Breaking News |
| Genentech Fails to Sway FDA Panel | July 20, 2010 | Xconomy Life Sciences |
| Genentech Disappointed With FDA Panel On Avastin | July 20, 2010 | Health News - Fox Business |
| Genentech Provides Update from Avastin FDA Advisory Committee Meeting | July 20, 2010 | FDA News - Business Wire |
| New Genentech Bevacizumab Data Fails to Support Use in Advanced Breast Cancer | July 19, 2010 | BioSpace |
| Biogen Idec, Inc. (Massachusetts) And Genentech's Rituximab Shows Promise for Severe ANCA-Associated Vasculitis | July 15, 2010 | BioSpace |
| Research and Markets: US Biotechnology Sector Industry Report: 1500 Companies such as Amgen, Biogen Idec, Genentech with Combined Annual Revenue of Ap | July 13, 2010 | Biotechnology - Moreover |
| Genentech licenses UK package of small molecule drugs | July 12, 2010 | FierceBiotech |
| Genentech Nabs License to MRC Technology's CNS Disease Candidates | July 12, 2010 | BioSpace |
| MRC Technology, Genentech Enter Drug Pact | July 12, 2010 | Contract Pharma |
| US Biotechnology Sector Industry Report: 1500 Companies such as Amgen, Biogen Idec, Genentech with Combined Annual Revenue of Approx $70 Billion | July 12, 2010 | Biotechnology - Moreover |
| Research and Markets: US Biotechnology Sector Industry Report: 1500 Companies such as Amgen, Biogen Idec, Genentech with Combined Annual Revenue of Approx $70 Billion | July 12, 2010 | Biotechnology - Moreover |
| Genentech Seeks FDA Approval for New Breast Cancer Drug | July 09, 2010 | Burrill Report |
| Roche Owned Genentech Submits Breast Cancer Drug For FDA Approval; Says Drug Could Rake in Sales of $1.88 Billion | July 07, 2010 | BioSpace |
| Genentech Submits T-DM1 BLA | July 07, 2010 | Contract Pharma |
| Genentech Seeks FDA Nod for T-DM1 | July 07, 2010 | Xconomy Life Sciences |
| Genentech Submits Application to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-Positive Breast Cancer | July 07, 2010 | FDA News - Business Wire |
| Genentech Release: Second Phase III Study Showed Avastin-Containing Regimen Helped Women With Ovarian Cancer Live Longer Without Their Disease Getting Worse | July 06, 2010 | BioSpace - Breaking News |
| Genentech Culture Intact After Roche Takeover | July 06, 2010 | BioSpace |
| Genentech brings ops savvy, pipeline to Roche | July 06, 2010 | FiercePharma Manufacturing |
| Post-merger, Roche emulates Genentech's attitude | July 02, 2010 | FierceBiotech |
| Genentech obtains expanded FDA approval of eye drug Lucentis | June 24, 2010 | Biotechnology - Moreover |
| Genentech says Lucentis gets added FDA approval | June 23, 2010 | Health News - CNBC |
| FDA Approves Genentech's Lucentis(R) (Ranibizumab Injection) for the Treatment of Macular Edema Following Retinal Vein Occlusion | June 23, 2010 | BioSpace |
| Genentech says Lucentis gets new FDA approval | June 23, 2010 | Health News - CNBC |
| FDA OKs Genentech drug against blindness | June 23, 2010 | Health News - BizJournals.com |
| Genentech's Avastin meets goals in cancer study | June 07, 2010 | Health News - CNBC |
| Trubion Pharmaceuticals Inc. Wins Genentech and Biogen Idec, Inc. (Massachusetts) Patent Appeal | June 04, 2010 | BioSpace - Breaking News |
| Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal | June 03, 2010 | Pharma News - PR Newswire |
| Bioengineering: Researchers from Genentech discuss findings in bioengineering | May 30, 2010 | Biotechnology - Moreover |
| Genentech Uses Complete Genomics’ Human Genome Sequencing Service to Compare Tumor and Normal Genome in Patient with Non-small Cell Lung Cancer; Results Published in Nature | May 27, 2010 | Pharma News - PharmiWeb |
| Roche and Genentech to Present New Data on Different Approaches to Treating Cancer at ASCO | May 20, 2010 | Pharma News - Business Wire |
| Evotec AG Enters Into Integrated Drug Discovery Alliance With Genentech | May 10, 2010 | BioSpace - Breaking News |
| Evotec, Genentech Enter Drug Discovery Alliance | May 10, 2010 | Contract Pharma |
| Evotec, Roche's Genentech In Drug-discovery Pact | May 10, 2010 | Health News - Fox Business |
| FDA warns Genentech on Rituxan promos | May 06, 2010 | Health News - BizJournals.com |
| New licensing chiefs for AZ, Genentech talk deal strategy | May 05, 2010 | FierceBiotech |
| Genentech's Drug-Laser Combination Proves Effective For Diabetic Blindness, Johns Hopkins University Study | April 28, 2010 | BioSpace |
| Genentech Submits Herceptin Chemo Application to FDA | April 28, 2010 | Pharmaceutical - Moreover |
| A Genentech Eye Treatment Is Found to Help Prevent Vision Loss in Diabetics | April 27, 2010 | New York Times- Pharmaceuticals |
| Positive Results in a Test for a Genentech Eye Treatment | April 27, 2010 | New York Times- Pharmaceuticals |
| Onkologen in den USA und in den 5 wichtigsten EU-Mrkten stellen Roche/Genentech bei der Kundenbindung an die erste Stelle | April 23, 2010 | Marketwire - Pharma and Biotech |
| Los onclogos de Estados Unidos y de 5 pases de la UE califican a Roche/Genentech como n 1 en retencin de clientes | April 23, 2010 | Marketwire - Pharma and Biotech |
| Les oncologues amricains et 5 oncologues europens notent Roche/Genentech n1 en matire de fidlisation de la clientle. | April 23, 2010 | Marketwire - Pharma and Biotech |
| Genentech Submits Herceptin sNDA in Stomach Cancer | April 23, 2010 | Contract Pharma |
| Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer | April 23, 2010 | Pharma News - Business Wire |
| US and 5 EU Oncologists Rate Roche/Genentech #1 on Customer Retention | April 22, 2010 | Marketwire - Pharma and Biotech |
| Former Genentech CEO Levinson joins Amyris' board | April 21, 2010 | FierceBiotech |
| Seattle Genetics, Inc. to Receive $9.5 Million Payment from Genentech to Extend Antibody-Drug Conjugate Collaboration | April 20, 2010 | BioSpace |
| Seattle Genetics, Genentech Renew Pact | April 20, 2010 | Contract Pharma |
| Seattle Genetics to Receive $9.5 Million Payment from Genentech to Extend Antibody-Drug Conjugate Collaboration | April 20, 2010 | Pharma News - Business Wire |
| Genentech a believer in Google online sharing apps | April 15, 2010 | FierceBiotech IT |
| Oregon's wooing pulls Genentech north for $400M facility | April 12, 2010 | FiercePharma Manufacturing |
| Genentech (RHHBY) Nears Completion of $4 | April 08, 2010 | Biotechnology - Moreover |
| Genentech Nears Completion of $400 Million Plant, 50 New Jobs Expected | April 08, 2010 | BioSpace |
| Genentech nears completion of $400M plant | April 06, 2010 | Health News - BizJournals.com |
| Genentech and Biogen Idec file complaint against GSK | March 29, 2010 | Biotechnology - Moreover |
| Genentech Splashes into 2010 with Positive Job Growth Expectations: Exclusive Interview with Talent Acquisition Leader | March 25, 2010 | BioSpace |
| Genentech looking to hire smart, creative types | March 25, 2010 | FierceBiotech |
| Biotechs, VCs Shoot, Score with Reform; Legislation Gives Brand Name Drug Developers Like Genentech (South SF) (RHHBY) And Amgen (AMGN) | March 23, 2010 | Biotechnology - Moreover |
| Biotechs, VCs Shoot, Score with Reform; Legislation Gives Brand Name Drug Developers Like Genentech (South SF) And Amgen 12 Years of Data Exclusivity | March 23, 2010 | BioSpace |
| Rheumatologists Are Eager to Use Roche-Genentech's ACTEMRA, According to New Study by BioTrends | March 18, 2010 | Medical Pharma - PR Newswire |
| Genentech hires Cytokinetics founder for new position | March 18, 2010 | Health News - BizJournals.com |
| Genentech Submits Actemra sBLA | March 17, 2010 | Contract Pharma |
| Genentech (South SF) Submits Supplemental Biologics License Application for ACTEMRA(R) (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis | March 16, 2010 | BioSpace - Breaking News |
| Genentech Submits Supplemental Biologics License Application for ACTEMRA® (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis | March 16, 2010 | Pharma News - Business Wire |
| Genentech (South SF) Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer | March 12, 2010 | BioSpace - Breaking News |
| Roche Holding AG, Genentech (South SF)'s Avastin Fails in Prostate Cancer Study | March 12, 2010 | BioSpace |
| Genentech Inc reports Phase III study of Avastin in advanced prostate cancer did not meet primary objective | March 12, 2010 | Biotechnology - Moreover |
| Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer | March 12, 2010 | Pharma News - Business Wire |
| Seattle Genetics Reaches Genentech Milestone | March 03, 2010 | Contract Pharma |
| Ex-Genentech boss elected to Roche board | March 02, 2010 | Health News - BizJournals.com |
| Genentech: Avastin strong in ovarian cancer trial | February 25, 2010 | Health News - BizJournals.com |
| Genentech (South SF) Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer | February 25, 2010 | BioSpace |
| Genentech (South SF) Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer | February 25, 2010 | BioSpace |
| Genentech Gets Positive Phase III Avastin Results | February 25, 2010 | Contract Pharma |
| Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer | February 25, 2010 | Pharma News - Business Wire |
| Genentech's Avastin fails stomach cancer trial | February 23, 2010 | Health News - BizJournals.com |
| Genentech (South SF)'s Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint | February 23, 2010 | BioSpace |
| FDA: Genentech HIV drug, booster combo may have side effects | February 23, 2010 | Health News - BizJournals.com |
| Genentech (South SF)'s Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint | February 23, 2010 | BioSpace |
| UCSF, Genentech strike $13M deal | February 22, 2010 | Health News - BizJournals.com |
| Genentech and UCSF to join forces on drug development | February 19, 2010 | FierceBiotech |
| Genentech and UCSF’s Small Molecule Discovery Center Ink Deal Targeting Neurodegenerative Diseases | February 19, 2010 | GEN News Highlights |
| Research and Markets: Partnering Agreements with Genentech 2010 - An In-Depth Insight into One of the Worlds Leading Biopharma Companies | February 12, 2010 | Pharma News - Business Wire |
| Swiss Roche annual net profit down over Genentech buyout | February 03, 2010 | Biotechnology - Moreover |
| Genentech deal weighs on Roche figures | February 03, 2010 | Biotechnology - Moreover |
| Roche 2009 profit down 22 pct on Genentech costs | February 03, 2010 | Health News - CNBC |
| Roche annual net profit down over Genentech buyout | February 03, 2010 | Biotechnology - Moreover |
| Roche full-year net profit down 22 pct to US$8.06 billion on Genentech takeover costs | February 03, 2010 | Health News - CNBC |
| Roche FY net profit down 22 pct on Genentech costs | February 03, 2010 | Health News - CNBC |
| Genentech says FDA approves Actemra arthritis drug | January 24, 2010 | Biotechnology - Moreover |
| Gov. Bev Perdue, Genentech s Krognes, Talecris Stern Among Keynote Presenters At CED s Biotech 2010 Conference | January 22, 2010 | Biotechnology - Moreover |
| Gov. Bev Perdue, Genentech's Krognes, Talecris' Stern Among Keynote Presenters At CED's Biotech 2010 Conference | January 20, 2010 | Biotechnology - Moreover |
| Gov. Bev Perdue, Genentech's Krognes, Talecris' Stern Among Keynote Presenters At CED's Biotech... | January 20, 2010 | Biotechnology - Moreover |
| Amid closures and cuts, Genentech starts building | January 12, 2010 | FiercePharma |
| FDA approves Genentech's Actemra | January 11, 2010 | Health News - BizJournals.com |
| Genentech to build new S.S.F. office building | January 11, 2010 | Health News - BizJournals.com |
| Genentech to build new office building | January 11, 2010 | Health News - BizJournals.com |
| Genentech says FDA approves Actemra arthritis drug
(AP)
| January 09, 2010 | Yahoo Biotech News |
| Genentech (South SF) , Roche Pare Partnerships; Assures Big Bio that "Nothing's Changed" | December 21, 2009 | BioSpace - Breaking News |
| Genentech (South SF), Roche Pare Partnerships; Assures Big Bio that "Nothing's Changed" | December 21, 2009 | BioSpace |
| Roche, Genentech try to calm jittery partners | December 21, 2009 | FierceBiotech |
| FDA panel snubs Genentech lung cancer drug | December 16, 2009 | Health News - BizJournals.com |
| FDA panel won't recommend Genentech drug | December 16, 2009 | Health News - BizJournals.com |
| Genentech wants lung cancer drug expanded | December 15, 2009 | Health News - BizJournals.com |
| Roche Unit Genentech (South SF) and Biogen Idec, Inc. (Massachusetts) Meet Primary Endpoint on Phase III Study into Rheumatoid Arthritis Treatment | December 11, 2009 | BioSpace |
| Seattle Genetics, Inc. Announces Termination of Collaboration Agreement with Genentech (South SF) for Dacetuzumab (SGN-40) | December 11, 2009 | BioSpace |
| Genentech scrubs Seattle Genetics deal | December 11, 2009 | Health News - BizJournals.com |
| Genentech sheds $860M Seattle Genetics pact | December 11, 2009 | FierceBiotech |
| Genentech and Biogen Idec Report Positive Late-Stage Data with RA Therapy | December 11, 2009 | GEN News Highlights |
| Genentech and Biogen Idec Report Positive Phase III Results with RA Therapy | December 11, 2009 | GEN News Highlights |
| Genentech Ends Collaboration with Seattle Genetics for Phase I Anticancer mAb | December 11, 2009 | GEN News Highlights |
| Roche Unit Genentech (South SF) and Biogen Idec, Inc. (Massachusetts) Meet Primary Endpoint on Phase III Study into Rheumatoid Arthritis Treatment | December 11, 2009 | BioSpace |
| Seattle Genetics, Inc. Announces Termination of Collaboration Agreement with Genentech (South SF) for Dacetuzumab (SGN-40) | December 11, 2009 | BioSpace |
| Genentech Cancels Seattle Genomics MAb Pact | December 11, 2009 | Contract Pharma |
| Genentech sheds pact as pipeline review claims another deal | December 11, 2009 | FierceBiotech |
| Genentech (South SF) And Biogen Idec, Inc. (California) Release: Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia | December 08, 2009 | BioSpace - Breaking News |
| Roche dumps another partner as it focuses on Genentech | December 08, 2009 | FierceBiotech |
| Seattle Genetics, Genentech Lymphoma Drug Passes Early Test with “Naked” Antibody | December 07, 2009 | Xconomy Life Sciences |
| Genentech insists it hasn't lost its R&D mojo | November 30, 2009 | FierceBiotech |
| Lawmakers used Genentech statements: report
(Reuters)
| November 15, 2009 | Yahoo Biotech News |
| Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis | | Pharma News - Business Wire |
| Seattle Genetics Announces Termination of Collaboration Agreement with Genentech for Dacetuzumab (SGN-40) | | Pharma News - Business Wire |
| Genentech obtains proof of concept for hedgehog inhibition | | Nature Biotechnology |
